Vaccine stocks on watch as AstraZeneca's (AZN) COVID19 vaccine study put on hold
- Wall Street extends rally as value stocks bounce
- China Tells Local Authorities to Prepare For a 'Possible Storm' and Prevent Unrest as Evergrande Crisis Unravels - WSJ
- Salesforce (CRM) Raises FY22 Revenue Guidance; Initiates FY23 Revenue
- Oil prices rise, hit 2-month highs on supply worries
- IDFA Seen as a 'Real Headwind' for Facebook (FB) but Analysts Remain Positive
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
Vaccine stocks on watch as AstraZeneca (NYSE: AZN) COVID19 vaccine study put on hold due to suspected adverse reaction in participant in the UK - STAT
Related vaccine stocks:
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pressure Growing on Moderna (MRNA) and Pfizer (PFE) to Share Covid Vaccine Formulas - Report
- Lightspeed POS Inc. (LSPD) Gains on Toast IPO, Valuation
- DraftKings (DKNG) said new short at Hedgeye
Create E-mail Alert Related CategoriesFDA, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!